Title: Prevalence and Clinical Outcomes for Patients With ALK-Positive Resected Stage I to III Adenocarcinoma: Results From the European Thoracic Oncology Platform Lungscape Project
Authors: Blackhall, Fiona H ×
Peters, Solange
Bubendorf, Lukas
Dafni, Urania
Kerr, Keith M
Hager, Henrik
Soltermann, Alex
O'Byrne, Kenneth J
Dooms, Christophe
Sejda, Aleksandra
Hernández-Losa, Javier
Marchetti, Antonio
Savic, Spasenija
Tan, Qiang
Thunnissen, Erik
Speel, Ernst-Jan M
Cheney, Richard
Nonaka, Daisuke
de Jong, Jeroen
Martorell, Miguel
Letovanec, Igor
Rosell, Rafael
Stahel, Rolf A #
Issue Date: Sep-2014
Publisher: Grune & Stratton
Series Title: Journal of Clinical Oncology vol:32 issue:25 pages:2780-7
Article number: 10.1200/JCO.2013.54.5921
Abstract: The prevalence of anaplastic lymphoma kinase (ALK) gene fusion (ALK positivity) in early-stage non-small-cell lung cancer (NSCLC) varies by population examined and detection method used. The Lungscape ALK project was designed to address the prevalence and prognostic impact of ALK positivity in resected lung adenocarcinoma in a primarily European population.
ISSN: 0732-183X
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Pneumology
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science